Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients


Date

2018-12-01

Publication Type

Journal Article

ETH Bibliography

yes

Citations

Altmetric

Data

Abstract

Glioma is difficult to detect or characterize using current liquid biopsy approaches. Detection of cell‐free tumor DNA (cftDNA) in cerebrospinal fluid (CSF) has been proposed as an alternative to detection in plasma. We used shallow whole‐genome sequencing (sWGS, at a coverage of < 0.4×) of cell‐free DNA from the CSF of 13 patients with primary glioma to determine somatic copy number alterations and DNA fragmentation patterns. This allowed us to determine the presence of cftDNA in CSF without any prior knowledge of point mutations present in the tumor. We also showed that the fragmentation pattern of cell‐free DNA in CSF is different from that in plasma. This low‐cost screening method provides information on the tumor genome and can be used to target those patients with high levels of cftDNA for further larger‐scale sequencing, such as by whole‐exome and whole‐genome sequencing.

Publication status

published

Editor

Book title

Volume

10 (12)

Pages / Article No.

Publisher

EMBO Press

Event

Edition / version

Methods

Software

Geographic location

Date collected

Date created

Subject

cell-free DNA; cerebrospinal fluid; fragmentation; glioma; shallow WGS

Organisational unit

Notes

Funding

Related publications and datasets